Nanoparticle-based drug delivery systems targeting cancer cell surfaces

L Hong, W Li, Y Li, S Yin - RSC advances, 2023 - pubs.rsc.org
Traditional cancer chemotherapy easily produces serious toxic and side effects due to the
lack of specific selection of tumor cells, which restricts its curative effect. Targeted delivery …

Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy

A Ayati, S Moghimi, M Toolabi, A Foroumadi - European Journal of …, 2021 - Elsevier
Despite significant improvements of new treatment options, cancer continues to represent as
one of the most common and fatal disease. The EGFR signaling pathway is considered as a …

The emergence of drug resistance to targeted cancer therapies: Clinical evidence

AB Sarmento-Ribeiro, A Scorilas, AC Gonçalves… - Drug Resistance …, 2019 - Elsevier
For many decades classical anti-tumor therapies included chemotherapy, radiation and
surgery; however, in the last two decades, following the identification of the genomic drivers …

Chimeric HDAC inhibitors: Comprehensive review on the HDAC‐based strategies developed to combat cancer

HM Hesham, DS Lasheen… - Medicinal Research …, 2018 - Wiley Online Library
Recently, molecular hybridization paradigm became an interesting and smart way to defeat
the multifaceted cancer disease by a single molecular entity that acts via several …

Design, synthesis and anticancer evaluation of 1H-pyrazolo [3, 4-d] pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers

AA Gaber, AH Bayoumi, AM El-Morsy, FF Sherbiny… - Bioorganic …, 2018 - Elsevier
In our attempt to develop effective EGFR-TKIs, two series of 1H-pyrazolo [3, 4-d] pyrimidine
derivatives were designed and synthesized. All the newly synthesized compounds were …

Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors

B Sever, MD Altıntop, MO Radwan, A Özdemir… - European journal of …, 2019 - Elsevier
Epidermal growth factor receptor (EGFR, also known as HER1) and HER2, prominent
members of receptor tyrosine kinase (RTK) superfamily, have been reported as diagnostic or …

Structure–activity relationship studies based on quinazoline derivatives as EGFR kinase inhibitors (2017–present)

A Șandor, I Ionuț, G Marc, I Oniga, D Eniu, O Oniga - Pharmaceuticals, 2023 - mdpi.com
The epidermal growth factor receptor (EGFR) plays a critical role in the tumorigenesis of
various forms of cancer. Targeting the mutant forms of EGFR has been identified as an …

Thieno [2, 3-d] pyrimidine as a promising scaffold in medicinal chemistry: Recent advances

EMH Ali, MS Abdel-Maksoud, CH Oh - Bioorganic & medicinal chemistry, 2019 - Elsevier
Thienopyrimidine scaffold is a fused heterocyclic ring system that structurally can be
considered as adenine, the purine base that is found in both DNA and RNA-bioisosteres …

Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry

D Das, J Hong - European Journal of Medicinal Chemistry, 2019 - Elsevier
The 4-aminoquinazoline core is an interesting pharmacophore and its applications in
medicinal chemistry are wide spread. The core has been used for making many kinase …

Recent updates on thienopyrimidine derivatives as anticancer agents

MTM Sayed, RA Hassan, PA Halim… - Medicinal Chemistry …, 2023 - Springer
Thienopyrimidine derivatives hold a unique place between fused pyrimidine compounds.
They are important and widely represented in medicinal chemistry as they are structural …